Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wenzel

Headache

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Headache|November 12, 2020
Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster HeadacheDavid Kudrow, J Scott Andrews, Mallikarjuna Rettiganti, et al.
Headache|November 22, 2021
Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatmentMiguel J A Láinez, Jean Schoenen, Chad Stroud, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Headache|November 12, 2020
Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster HeadacheDavid Kudrow, J Scott Andrews, Mallikarjuna Rettiganti, et al.
Headache|November 22, 2021
Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatmentMiguel J A Láinez, Jean Schoenen, Chad Stroud, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
Pageof 1